Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

NHC

NHC President & COO to Retire After 45 Years

National Healthcare Corporation (NHC) has announced the retirement of R. Michael Ussery, the company's President and Chief Operating Officer, effective December 31, 2025, after a distinguished 45-year career with the organization.

During his tenure, Ussery played a pivotal role in guiding NHC through significant periods of change and growth. Under his leadership, NHC has continued to reinforce its culture centered on high-quality patient care.

NHC, which operates 80 skilled nursing facilities with 10,349 beds, 26 assisted living communities with 1,413 units, nine independent living communities with 777 units, three behavioral health hospitals, 34 homecare agencies, and 32 hospice agencies, has seen remarkable progress and development during Ussery's time as President and COO.

The company's continued commitment to exceptional care is reflected in its services, which include Alzheimer's and memory care units, pharmacy services, a rehabilitation services company, and providing management and accounting services to third-party post-acute operators.

Ussery's retirement marks the end of a career characterized by dedication, commitment, and outstanding leadership that has contributed significantly to NHC's success and growth. His departure leaves a legacy of integrity and exceptional work ethic at NHC.

As NHC prepares for this transition, the company's future looks promising, and it is poised to continue thriving under the leadership of the team that will carry the organization forward. Following these announcements, the company's shares moved 3.38%, and are now trading at a price of $126.41. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS